DHS 157.71(26)(b)3. 3. Each dose rate measured around the source while the unit is in the off position and the average of all measurements.

DHS 157.71(26)(b)4. 4. The signature of the person who performed the test.

DHS 157.71(27) (27) Records of 5-year inspection for teletherapy and gamma stereotactic radiosurgery units.

DHS 157.71(27)(a) (a) A licensee shall maintain a record of the 5-year inspections for teletherapy and gamma stereotactic radiosurgery units required by s. DHS 157.67 (15) for the duration of use of the unit.

DHS 157.71(27)(b) (b) The record required under par. (a) shall contain all the following:

DHS 157.71(27)(b)1. 1. The inspector’s radioactive materials license number.

DHS 157.71(27)(b)2. 2. The date of inspection.

DHS 157.71(27)(b)3. 3. The manufacturer’s name and model number and serial number of both the treatment unit and source.

DHS 157.71(27)(b)4. 4. A list of components inspected and serviced, and the type of service.

DHS 157.71(27)(b)5. 5. The signature of the inspector.

DHS 157.71(28) (28) Records of decay of strontium-90 sources for ophthalmic treatments.

DHS 157.71(28)(a) (a) A licensee shall maintain a record of the activity of a strontium-90 source required by s. DHS 157.65 (6) for the life of the source.

DHS 157.71(28)(b) (b) The record required under par. (a) shall include both of the following:

DHS 157.71(28)(b)1. 1. The initial activity of the source and date.

DHS 157.71(28)(b)2. 2. For each decay calculation, the date and the source activity as determined under s. DHS 157.65 (6).

DHS 157.71 History History: CR 01-108: cr. Register July 2002 No. 559, eff. — see Note at the start of the chapter; CR 06-021: r. and recr. (14) Register October 2006 No. 610, eff. 11-1-06; CR 16-078: am. (8) Register January 2018 No. 745, eff. 2-1-18; CR 22-015: cr. (1) (c), am. (4) (b) 3., (5) (c) Register June 2023 No. 810, eff. 7-1-23.

DHS 157.72 DHS 157.72 Reports.

DHS 157.72(1) (1) Reports of medical events.

DHS 157.72(1)(a) (a) A licensee shall report to the department any event, except for events that result from intervention by a patient or human research subject, in which the administration of radioactive material or resulting radiation, except for permanent implant brachytherapy, results in any of the following:

DHS 157.72(1)(a)1. 1. A dose that differs from the prescribed dose or dose that would have resulted from the prescribed dosage by more than 0.05 Sv (5 rem) effective dose equivalent, 0.5 Sv (50 rem) to an organ or tissue or 0.5 Sv (50 rem) shallow dose equivalent to the skin and to which any of the following apply:

DHS 157.72(1)(a)1.a. a. The total dose delivered differs from the prescribed dose by 20% or more.

DHS 157.72(1)(a)1.b. b. The total dosage delivered differs from the prescribed dosage by 20% or more or falls outside the prescribed dosage range.

DHS 157.72(1)(a)1.c. c. The fractionated dose delivered differs from the prescribed dose, for a single fraction, by 50% or more.

DHS 157.72(1)(a)2. 2. A dose that exceeds 0.05 Sv (5 rem) effective dose equivalent, 0.5 Sv (50 rem) to an organ or tissue or 0.5 Sv (50 rem) shallow dose equivalent to the skin from any of the following:

DHS 157.72(1)(a)2.a. a. An administration of a wrong pharmaceutical.

DHS 157.72(1)(a)2.b. b. An administration of a radioactive drug containing radioactive material by the wrong route of administration.

DHS 157.72(1)(a)2.c. c. An administration of a dose or dosage to the wrong patient or human research subject.

DHS 157.72(1)(a)2.d. d. An administration of a dose delivered by the wrong mode of treatment.

DHS 157.72(1)(a)2.e. e. A leaking sealed source.